FDA HAS RELEASED A SOCIAL MEDIA GUIDANCE

The US Food and Drug Administration (FDA) has released a draft guidance document that offers insights into how the agency thinks companies should use—and not use—social media channels.

Companies are now supposed to submit advertising and promotional documents to FDA through Form FDA-2253 (human) or 2301 (veterinary)  allowing FDA the opportunity to review materials instead of being forced to track them down themselves.

WHAT TO REPORT?

According to the guidance any materials posted to a social media site under direct or indirect control or influence of the firm must submit materials to FDA's OPDP, even if that influence is "limited in scope.”

WHEN TO REPORT?

In the case a company is participating in active ("real-time") discussions on Twitter, it will need to submit information to FDA on a monthly basis, with a listing of all websites. Though, it won’t have to submit screenshots of conversations.

Sites controlled by third parties on behalf of the company will be subject to the same monthly reporting schedule, according to FDA.

The guidance notes also stated that FDA will need to be notified "on the first day the firm ceases to be active on a site."

http://tinyurl.com/ox7srbb

#FDA   #socialmedia  
Photo
Shared publiclyView activity